Genmab AS ADS GMAB Q1 2026 Earnings EPS Miss Weighs on Shares as Revenue Picture Remains Unclear MLSS Q1 2026 Earnings NarrowerThanExpected Loss as Commercial Efforts Continue STKS Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Operational Headwinds Core Laboratories Q1 2026 Earnings EPS Misses Estimates by Wide Margin Shares Decline Evercore Q1 2026 Earnings Blowout EPS Beats Estimates by 4665 DNLI Q1 2026 Earnings Cost Discipline Drives EPS Beat Despite PreRevenue Status